Press Releases

AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Abe Sutton, JD, CMS director, on the AMA Moving Medicine video podcast

New voluntary CMS pay model encourages use of health tech

| 5 Min Read
Young adult in a telehealth appointment

New data details how telehealth use varies by physician specialty

| 4 Min Read
Mom holding baby gets medicine from doctor

The AMA is committed to reversing the maternal mortality crisis

| 5 Min Read
Young child holding throat with pained expression

What doctors wish patients knew about strep throat

| 11 Min Read